BioDelivery Sciences International, Inc. (BDSI)
(Delayed Data from NSDQ)
$4.84 USD
+0.08 (1.68%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.85 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[BDSI]
Reports for Purchase
Showing records 1 - 20 ( 651 total )
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BDSI.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BDSI.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Takeout By Collegium Is Good Exit At Fair Price; Target to $5.60
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BDSI.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BDSI.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Preliminary 4Q Upside; Spending Discipline Has Us Raising Projected Leverage, and PT to $4.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for BDSI.
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Belbuca Patent Win Relieves Downside Risk; Still Need to See Belbuca Acceleration, Good Elyxyb Launch; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Moving to Neutral; Opioid Space Weakness Remains a Belbuca Headwind and Elyxyb a 2022 -Show Me- Story; PT to $4.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: LIVNAT O
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
3Q21 Recap - Noisy Quarter; Still Waiting for Patent Case
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department